Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Your ultimate guide to the 2024 North Carolina State Fair
Recommended
Find a flu shot
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tiziana Life Sciences Ltd
(NQ:
TLSA
)
0.8790
-0.0170 (-1.90%)
Streaming Delayed Price
Updated: 3:59 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
127,048
Open
0.8760
Bid (Size)
0.8503 (11)
Ask (Size)
0.9400 (7)
Prev. Close
0.8960
Today's Range
0.8420 - 0.9000
52wk Range
0.4100 - 1.740
Shares Outstanding
194,612,289
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's After-Market Session
October 18, 2024
Via
Benzinga
Elon Musk May Unveil Tesla's Robotaxi, But Consumers Respond With 'Ehhh,' New Study Reveals Skepticism, Need For Trust-Building
October 10, 2024
Consumer support for robotaxis is low for people who have not been inside a self-driving vehicle or live in a city where the vehicles operate.
Via
Benzinga
Performance
YTD
+54.18%
+54.18%
1 Month
-20.55%
-20.55%
3 Month
-2.33%
-2.33%
6 Month
+16.64%
+16.64%
1 Year
+37.13%
+37.13%
More News
Read More
Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease
September 19, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Appoints New Chief Executive Officer
August 19, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
August 14, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
The 3 Best EV Stocks to Buy in August 2024
August 10, 2024
Via
InvestorPlace
Tiziana Life Sciences Granted FDA Fast Track Designation
July 24, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Receives $3.4 Million in Non-Dilutive Funding
June 28, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences adds to treasury with $3.4 million in non-dilutive funding
June 28, 2024
Via
News Direct
Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer’s Disease with Foralumab
June 26, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
June 17, 2024
Via
Benzinga
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
June 11, 2024
Via
FinancialNewsMedia
Exposures
Product Safety
FDA Accepts Tiziana Life Sciences Fast Track Designation Submission for Treatment of Multiple Sclerosis
June 11, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
June 11, 2024
From
FN Media Group LLC
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
June 07, 2024
Via
Benzinga
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
June 06, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intranasal Foralumab
June 04, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis Research
May 30, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
EXCLUSIVE: Top Tesla Options Trades Recommended By Trading Expert
May 15, 2024
Via
Benzinga
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
May 13, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Tiziana Life Sciences Reports Positive 3-Month Neuroimaging Scores in Multiple Sclerosis Patients Receiving Intranasal Foralumab
April 25, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 23, 2024
Via
Benzinga
Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program
April 23, 2024
From
Tiziana Life Sciences Ltd.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.